Subscribe to Newsletter

Business & Regulation

Business & Regulation Standards & Regulation

The Trump Effect on Biopharma: FDA Disruption, Tariffs, and Funding Cuts

| 5 min read

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.

Business & Regulation Profession

Denmark and Sweden Invite Misplaced US Scientists to the EU

| Rob Coker | 2 min read

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

Business & Regulation Standards & Regulation

This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US

| Stephanie Vine | 4 min read

Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more

Business & Regulation Standards & Regulation

US States Sue Over RFK Jr’s HHS Layoffs and Reorganization

| Stephanie Vine | 3 min read

Attorney Generals claim: “This administration is not streamlining the federal government; they are sabotaging it.”

Business & Regulation Profession

Starting a Business in CRISPR

| Stephanie Vine | 8 min read

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Business & Regulation Business Practice

Breaking Down Brain Barriers

| Agnese Cattaneo | 3 min read

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

Business & Regulation Profession

Medicine Making Pioneers

| Stephanie Vine

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Business & Regulation Trends & Forecasts

This Week’s Biopharma News: Roche’s $50 Billion Investment in the US and More

| 4 min read

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

Business & Regulation Trends & Forecasts

Quality Over Quantity: EMA's New Approach to Biosimilars

| Rob Coker | 2 min read

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Business & Regulation Standards & Regulation

Trump's New Push on Drug Pricing

| Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker